Thursday May 17 | PhysOrg Weblog
ASCO: For chemo's nausea, olanzapine beats metoclopramide
For patients receiving highly emetogenic chemotherapy who experience breakthrough chemotherapy-induced nausea and vomiting, treatment with olanzapine is significantly better than treatment with metoclopramide, according to a phase III study released May 16 in advance of presentation at the annual meeting of the American Society of Clinical ... (more)
The cognitive profile of aripiprazole differs from that of other...
We investigated the effects of the atypical antipsychotics risperidone, olanzapine, and aripiprazole on the cognitive functions of Japanese patients with schizophrenia with respect to dosage amounts and dosing schedules.
Jury may see video of police interview of Guelph murder suspect
Corinne Burns had a potentially dangerous level of an anti-psychotic drug in her body at the time of her sudden death in a west-side Guelph park four years ago, a Supreme Court of Justice jury heard Tuesday.
Arizona to get nearly $2M in Depakote settlements
Arizona is set to receive nearly $2 million from multistate settlements with Abbott Laboratories over allegations the company promoted the anti-seizure drug Depakote for uses that were not approved by the Food and Drug Administration.
Eli Lilly and Company Invests in UK Research Base
HOTBEDS Regional News US & Canada Biotech Bay Biotech Beach Genetown Pharm Country BioCapital BioMidwest Bio NC BioForest Southern Pharm BioCanada East US Device Europe Asia Eli Lilly has officially opened new research facilities at its R&D base in Erl Wood in Surrey.
Also on Topix